|
|
(79 intermediate revisions by 10 users not shown) |
Line 1: |
Line 1: |
| __NOTOC__
| | {{ACM}} {{SemRikken}} |
| {{Peptic Ulcer Diease}} | |
|
| |
|
| {{CMG}}; {{AE}} : {{MKK}}
| |
| ==Overview==
| |
| Peptic ulcer disease results from the distruption of the normal epithelial lining of the walls of stomach and small intestine. The disrupted epithelium may sometimes be superimposed by Helicobacter pylori infection. Risk factors of peptic ulcer disease include ingestion of Non-Steroidal Inflammatory Drugs (NSAIDs), stress, .
| |
| *Helicobacter pylori-(previously called as Campylobacter pylori), gram-negative,helix-shaped, microaerophilic bacteria
| |
|
| |
|
| O
| | ''SANDBOX'' |
| | | [[File:Captura de Pantalla 2024-05-18 a la(s) 9.33.11 p.m..png]] |
| [Pathogen name] is usually transmitted via the [transmission route] route to the human host. | |
| | |
| OR
| |
| | |
| Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
| |
| | |
| OR
| |
| | |
| | |
| [Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
| |
| | |
| OR
| |
| | |
| The progression to [disease name] usually involves the [molecular pathway].
| |
| | |
| OR
| |
| | |
| The pathophysiology of [disease/malignancy] depends on the histological subtype.
| |
| | |
| ==Pathophysiology==
| |
| | |
| ===Pathogenesis===
| |
| *The exact pathogenesis of [disease name] is not fully understood.
| |
| OR
| |
| *It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
| |
| *[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
| |
| *Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
| |
| *[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
| |
| *The progression to [disease name] usually involves the [molecular pathway].
| |
| *The pathophysiology of [disease/malignancy] depends on the histological subtype.
| |
| | |
| ==Genetics==
| |
| *[Disease name] is transmitted in [mode of genetic transmission] pattern.
| |
| *Genes involved in the pathogenesis of [disease name] include [gene1], [gene2], and [gene3].
| |
| *The development of [disease name] is the result of multiple genetic mutations.
| |
| ==Associated Conditions==
| |
| | |
| ==Gross Pathology==
| |
| *On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
| |
| | |
| ==Microscopic Pathology==
| |
| *On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
| |
| | |
| ==References==
| |
| {{Reflist|2}}
| |
| | |
| {{WH}}
| |
| {{WS}}
| |
| [[Category: (name of the system)]]
| |